Interview: Gino Martel, Partner, BCF Business Law, Canada
Gino Martel explains the present environment for M&As, divestitures and out-licensing in the Canadian biotech…
BCF Business Law
Last updated: 13.02.2014
In 1995, BCF was formed by nine visionary individuals determined to transform the way business law was practiced. Quebec companies and young legal talent immediately embraced BCF’s pioneering approach. The firm experienced rapid growth as a result, which led to it opening an office in Quebec City to meet the demands of a growing clientele for its innovative services.
In providing services based on the core values of humility, creativity, generosity, intensity and sincerity, BCF has gained the trust of businesses in all sectors of activity throughout Quebec, across Canada and internationally.
Today, BCF’s innovative and collaborative approach continues to make it an outstanding firm.
QUEBEC CITY
Complexe Jules-Dallaire, T12828 Laurier Blvd., 12th Floor
Quebec City, Quebec G1V 0B9
CANADA
tel.: 418 266-4500
fax: 418 266-4515
info@bcf.ca
Interviews
Related
Canada / Federal Consultations on a National Strategy for Rare Disease Drugs
Writing in the March edition of DIA’s Global Forum magazine, Judith Glennie examines the findings of Health…
Canada / The Evolution of Medical Cannabis Legislation
Clint Sharples, CEO of Heritage Cannabis, gives a potted history of the medical cannabis industry in Canada, its…
Canada / Has the Time Truly Come for Trudeau’s ‘National Pharmacare’?
As the only country in the world to boast a universal healthcare system that does not cover prescription drugs,…
Canada / Pharma News Roundup September 2020
The latest news from Canadian pharma including deals for J&J’s and Novavax’s COVID-19 vaccines, an abrupt…
Pricing / Drugmakers Push Back Against Canada's New Regulations
Pushback from drug companies on Canada’s newest drug pricing regulations has led the country’s regulatory…
Alzheimer's / Canadian-Led Innovation Post-Aducanumab
Dr Neil Cashman looks at the potential impact of US FDA approval for Biogen’s aducanumab on the search for…
Canada / Global Pharma has Reinvented R&D: Will Canadian Start-Ups Lead the Next Phase?
John L. Wallace of Antibe Therapeutics highlights how Canadian innovation stands to put the country at the…
Opinion / A New Approach to Rare Diseases in Canada
Pamela Fralick of Innovative Medicines Canada (IMC) advocates for a collaborative multi-stakeholder approach to…
Pharma Faces / Marina Vasiliou, Biogen Canada
Marina Vasiliou took the reins as managing director of Biogen Canada in November 2017 after a long and varied…
Canada / Collective Impact in the Health Charity Sector
Diabetes Canada’s Jan Hux outlines how her organization has been able to shift from small, local programs to…
Patents: A Key Factor in Winning the Cannabis Arms Race
A new white paper from Fasken law firm asserts that the early filing of patents for innovative products is crucial…
Comprehensive Access to Medicines should be the Priority for National Pharmacare…
Canada is the only developed country with a universal healthcare system that does not provide universal coverage of…
